 Home > Medical News > Latest Medical News > Junshi Launches Head-to-Head Phase III Clinical Trial of New Crown Oral Drug VV116 Compared with Pfizer's Paxlovid

Junshi Launches Head-to-Head Phase III Clinical Trial of New Crown Oral Drug VV116 Compared with Pfizer's Paxlovid

 Last Update: 2022-05-18
 Source: Internet
 Author: User

Tags

cephalexin drug

tlc drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 19, the website of the China Clinical Trials Registry announced a multi-center, single-blind, randomized, controlled clinical study of Junshi Bio/Wangshan Wangshui VV116 head-to-head versus Pfizer Paxlovid in the early treatment of mild to severe new coronary pneumonia

According to public information, VV116 is a new oral nucleoside anti-SARS-CoV-2 drug jointly developed by Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Wuhan Institute of Virology, Chinese Academy of Sciences, and Wangshan Wangshui Biomedicine Co.

Paxlovid is an oral new crown drug developed by Pfizer.

The Phase III clinical plan enrolled 480 patients with mild to moderate Covid-19, randomized 1:1, with 240 in the treatment group and 240 in the control group, receiving VV116 or Paxlovid treatment.

Reference source: medical cube info, medical notes

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.